Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma.

Hsu SY, Yu HY, Lee WC, Hsiao CE, Wu CL, Cheng HT, Lin LJ, Li F, Chou YT, Cheng JW.

Onco Targets Ther. 2019 Sep 16;12:7611-7621. doi: 10.2147/OTT.S215824. eCollection 2019.


A novel CXCL8-IP10 hybrid protein is effective in blocking pulmonary pathology in a mouse model of Klebsiella pneumoniae infection.

Chen Z, Chen X, Cheng HT, Yeh SC, Yu HY, Cheng JW, Li F.

Int Immunopharmacol. 2018 Sep;62:40-45. doi: 10.1016/j.intimp.2018.06.040. Epub 2018 Jul 3.


High Level Expression and Purification of the Clinically Active Antimicrobial Peptide P-113 in Escherichia coli.

Cheng KT, Wu CL, Yip BS, Yu HY, Cheng HT, Chih YH, Cheng JW.

Molecules. 2018 Mar 30;23(4). pii: E800. doi: 10.3390/molecules23040800.


Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8(3-72)K11R/G31P.

Cheng HT, Yu HY, Gordon JR, Li F, Cheng JW.

Molecules. 2017 Jul 21;22(7). pii: E1229. doi: 10.3390/molecules22071229.


Ultrashort Antimicrobial Peptides with Antiendotoxin Properties.

Chih YH, Lin YS, Yip BS, Wei HJ, Chu HL, Yu HY, Cheng HT, Chou YT, Cheng JW.

Antimicrob Agents Chemother. 2015 Aug;59(8):5052-6. doi: 10.1128/AAC.00519-15. Epub 2015 Jun 1.


Novel antimicrobial peptides with high anticancer activity and selectivity.

Chu HL, Yip BS, Chen KH, Yu HY, Chih YH, Cheng HT, Chou YT, Cheng JW.

PLoS One. 2015 May 13;10(5):e0126390. doi: 10.1371/journal.pone.0126390. eCollection 2015.


Correlations between membrane immersion depth, orientation, and salt-resistance of tryptophan-rich antimicrobial peptides.

Yu HY, Yip BS, Tu CH, Chen HL, Chu HL, Chih YH, Cheng HT, Sue SC, Cheng JW.

Biochim Biophys Acta. 2013 Nov;1828(11):2720-8. doi: 10.1016/j.bbamem.2013.07.020. Epub 2013 Jul 27.


Boosting salt resistance of short antimicrobial peptides.

Chu HL, Yu HY, Yip BS, Chih YH, Liang CW, Cheng HT, Cheng JW.

Antimicrob Agents Chemother. 2013 Aug;57(8):4050-2. doi: 10.1128/AAC.00252-13. Epub 2013 May 28.


Easy strategy to increase salt resistance of antimicrobial peptides.

Yu HY, Tu CH, Yip BS, Chen HL, Cheng HT, Huang KC, Lo HJ, Cheng JW.

Antimicrob Agents Chemother. 2011 Oct;55(10):4918-21. doi: 10.1128/AAC.00202-11. Epub 2011 Jul 18.


Rational design of tryptophan-rich antimicrobial peptides with enhanced antimicrobial activities and specificities.

Yu HY, Huang KC, Yip BS, Tu CH, Chen HL, Cheng HT, Cheng JW.

Chembiochem. 2010 Nov 2;11(16):2273-82. doi: 10.1002/cbic.201000372.


Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein.

Chen HL, Her SY, Huang KC, Cheng HT, Wu CW, Wu SC, Cheng JW.

Biopolymers. 2010;94(3):331-8. doi: 10.1002/bip.21371.


A new protocol for high-yield purification of recombinant human CXCL8((3-72))K11R/G31P expressed in Escherichia coli.

Cheng HT, Huang KC, Yu HY, Gao KJ, Zhao X, Li F, Town J, Gordon JR, Cheng JW.

Protein Expr Purif. 2008 Sep;61(1):65-72. doi: 10.1016/j.pep.2008.04.007. Epub 2008 May 1.


Solution structure of a novel D-naphthylalanine substituted peptide with potential antibacterial and antifungal activities.

Wu JM, Wei SY, Chen HL, Weng KY, Cheng HT, Cheng JW.

Biopolymers. 2007;88(5):738-45.


Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase.

Huang KC, Cheng HT, Pai MT, Tzeng SR, Cheng JW.

J Biomol NMR. 2006 Sep;36(1):73-8. Epub 2006 Sep 13. No abstract available.


Supplemental Content

Loading ...
Support Center